Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 (A) Effects of ACEi therapy on 30-day incidence of persistent hypotension and renal dysfunction in the presence and absence of concomitant ASA. (B) Effects of ACEi therapy on 30-day incidence of heart failure, reinfarction and stroke in the presence and absence of concomitant ASA. *Percentages for heart failure are of patients surviving at day 30; **CONSENSUS-II patients are excluded from this analysis because data on stroke were not available.
|
